Evidence map›Paper›PMID 32705148›Full record

ReviewInternational journal of oncology2020

Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review).

Ondřej Kodet, Jan Kučera, Karolína Strnadová, Barbora Dvořánková, Jiří Štork, Lukáš Lacina, Karel Smetana

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Bioinformatics analysis identifiesAnnals of translational medicine · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ondřej KodetInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Jan KučeraInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Karolína StrnadováInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Barbora DvořánkováInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Jiří ŠtorkDepartment of Dermatovenereology, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic.
Lukáš LacinaInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Karel SmetanaInstitute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic.
Charles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of cutaneous malignant melanoma has been steadily increasing worldwide for several decades. This phenomenon seems to follow the trend observed in many types of malignancies caused by multiple significant factors, including ageing. Despite the progress in cutaneous malignant melanoma therapeutic options, the curability of advanced disease after metastasis represents a serious challenge for further research. In this review, we summarise data on the microenvironment of cutaneous malignant melanoma with emphasis on intercellular signalling during the disease progression. Malignant melanocytes with features of neural crest stem cells interact with non‑malignant populations within this microenvironment. We focus on representative bioactive factors regulating this intercellular crosstalk. We describe the possible key factors and signalling cascades responsible for the high complexity of the melanoma microenvironment and its premetastatic niches. Furthermore, we present the concept of melanoma early becoming a systemic disease. This systemic effect is presented as a background for the new horizons in the therapy of cutaneous melanoma.

Indexed as

Cell CommunicationTumor MicroenvironmentAnimalsBrain NeoplasmsDisease Models, AnimalDisease ProgressionHumansLung NeoplasmsMelanocytesMelanomaMiceSkinSkin Neoplasmscancer-associated fibroblastcancer microenvironmentchemokinecytokinegrowth factormelanoma

Identifiers

PMID32705148
PMCPMC7384852
OpenAlexW3038050524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.